Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs01:28

Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs

2.0K
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
2.0K
Analgesia and Pain Management01:25

Analgesia and Pain Management

2.7K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
2.7K
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

849
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
849
Antidepressant Drugs: MAOIs and Other Agents01:23

Antidepressant Drugs: MAOIs and Other Agents

1.1K
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
1.1K
Drugs for Treatment of Constipation-Predominant IBS01:21

Drugs for Treatment of Constipation-Predominant IBS

1.1K
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
1.1K
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

961
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
961

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same journal

Effect of Educational and Behavioral Interventions on Medication-Overuse Headache: A Systematic Review and Meta-Analysis.

Pain research & management·2026
Same journal

Association Between the Frailty Index and Self-Reported Headache in Middle-Aged and Older Chinese Adults: An Analysis of the China Health and Retirement Longitudinal Study.

Pain research & management·2026
Same journal

Calcific Tendinitis: A Pain-Oriented and Site-Specific Narrative Review.

Pain research & management·2026
Same journal

Functional Impact of Pain and Its Association With Sarcopenia in the Elderly: The Birjand Longitudinal Aging Study (BLAS).

Pain research & management·2026
Same journal

Comparison of Liposomal Bupivacaine for Single-Injection Versus Dual-Injection Thoracic Paravertebral Block on Analgesic Effect After Dual-Microport Thoracoscopic Lobectomy: A Prospective Randomized Controlled Trial.

Pain research & management·2026
Same journal

Development and Validation of a Multidimensional Psychometric Scale for Assessing Pain Perception and Coping Strategies Among Adolescents.

Pain research & management·2026

Related Experiment Video

Updated: Mar 17, 2026

Author Spotlight: Enhancing Women's Chronic Pelvic Pain Management Through Acupoint Catgut Embedding
02:41

Author Spotlight: Enhancing Women's Chronic Pelvic Pain Management Through Acupoint Catgut Embedding

Published on: May 3, 2024

2.4K

Treating Chronic Pain with SSRIs: What Do We Know?

Elias Patetsos1, Emilia Horjales-Araujo2

  • 1Copenhagen University, 2200 Copenhagen, Denmark.

Pain Research & Management
|July 23, 2016
PubMed
Summary

Selective Serotonin Reuptake Inhibitors (SSRIs) show potential for treating chronic pain conditions. However, more high-quality clinical trials are needed to confirm their effectiveness and establish definitive conclusions for this drug class.

More Related Videos

Treating Low Back Pain in Failed Back Surgery Patients with Multicolumn-lead Spinal Cord Stimulation
04:42

Treating Low Back Pain in Failed Back Surgery Patients with Multicolumn-lead Spinal Cord Stimulation

Published on: June 26, 2018

15.3K
Development of Recombinant Proteins to Treat Chronic Pain
10:37

Development of Recombinant Proteins to Treat Chronic Pain

Published on: April 11, 2018

10.1K

Related Experiment Videos

Last Updated: Mar 17, 2026

Author Spotlight: Enhancing Women's Chronic Pelvic Pain Management Through Acupoint Catgut Embedding
02:41

Author Spotlight: Enhancing Women's Chronic Pelvic Pain Management Through Acupoint Catgut Embedding

Published on: May 3, 2024

2.4K
Treating Low Back Pain in Failed Back Surgery Patients with Multicolumn-lead Spinal Cord Stimulation
04:42

Treating Low Back Pain in Failed Back Surgery Patients with Multicolumn-lead Spinal Cord Stimulation

Published on: June 26, 2018

15.3K
Development of Recombinant Proteins to Treat Chronic Pain
10:37

Development of Recombinant Proteins to Treat Chronic Pain

Published on: April 11, 2018

10.1K

Area of Science:

  • Neuroscience
  • Pharmacology
  • Pain Management

Background:

  • Serotonin is a key neurotransmitter influencing mood and pain perception.
  • Dysregulation of the serotonin system is observed in chronic pain patients.
  • Selective Serotonin Reuptake Inhibitors (SSRIs) offer a potentially better-tolerated alternative to traditional antidepressants for pain management.

Purpose of the Study:

  • To review the current evidence on the effectiveness of SSRIs in treating chronic pain conditions in adults.
  • To synthesize findings from existing clinical trials regarding SSRI efficacy for pain.

Main Methods:

  • A systematic review of 36 studies involving 1898 participants was conducted.
  • Included trials investigated various SSRIs such as fluoxetine, paroxetine, citalopram, sertraline, fluvoxamine, escitalopram, and zimelidine.
  • Due to heterogeneity, a qualitative analysis was performed.

Main Results:

  • SSRIs appear to influence various chronic pain conditions.
  • The overall effectiveness of SSRIs for chronic pain remains inconclusive due to study heterogeneity.
  • Specific SSRIs included in the review were fluoxetine (9 studies), paroxetine (8 studies), citalopram (6 studies), sertraline (4 studies), fluvoxamine (4 studies), escitalopram (3 studies), and zimelidine (2 studies).

Conclusions:

  • SSRIs demonstrate a potential therapeutic effect across multiple chronic pain conditions.
  • Further rigorous clinical trials with robust methodology and minimal bias are essential to definitively determine the role of SSRIs in chronic pain management.
  • The current evidence base necessitates cautious interpretation regarding SSRI efficacy for pain relief.